Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Accepts healthy volunteers

Impact of the Wingate Test on Post-activation Potentiation

ClinicalTrials.gov ID: NCT06779409

Public ClinicalTrials.gov record NCT06779409. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 7:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Comparing the Effects of Post Activation Potentiation on Vertical Jump Using High-Intensity Back Squat vs. Wingate Bike Test in Healthy Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this trial is to see if using a maximal effort, short cycling test is better at activating muscles to improve vertical jump height compared to a maximal effort back squat. The study looks to answer three questions: 1. will the Wingate bike test create a different change in counter movement jump height compared to a back squat? 2. What is the best recovery period after each test where the counter movement jump is the highest? 3. What person-specific factors predict success of the Wingate bike test as a activation activity for the counter movement jump? Participants will visit the lab 3 times, once to give informed consent and measure their 1 repetition max (RM) back squat, and twice to perform each intervention and measure vertical jump height.

Study identification

NCT ID
NCT06779409
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Enrollment
35 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 45 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 13, 2025
Primary completion
Apr 24, 2025
Completion
Apr 24, 2025
Last update posted
Jul 3, 2025

2025

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
LSU Health Shreveport School of Allied Health Professions Shreveport Louisiana 71103

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06779409, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 3, 2025 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06779409 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →